Shah Metacorp Limited, formerly known as Gyscoal Alloys Limited, has announced its unaudited financial results for the quarter ended September 30, 2025, along with significant corporate actions that may reshape the company's future.

Key Financial Highlights

The company's financial performance for the quarter ended September 30, 2025, reflects its ongoing operations and recent strategic moves. While specific financial figures for the quarter were not provided, the company's subsidiaries showed promising results for the half-year period:

These figures represent the combined performance of Shah Metacorp's four subsidiaries: Shah Agrocorp Private Limited, Western Urja Private Limited, General Capital and Holding Company Private Limited, and Metcorp Trading LLC.

Strategic Acquisitions

In a move to expand its business portfolio, Shah Metacorp has completed two significant acquisitions:

1. An 85.60% stake in General Capital and Holding Company Private Limited
2. An 80.00% stake in Metacorp Trading LLC

Both acquisitions were executed through share swap arrangements, with the company issuing and allotting equity shares on July 4, 2025. As a result, these entities have become subsidiaries of Shah Metacorp, potentially broadening the company's operational scope and market presence.

Equity Fundraising Activities

Shah Metacorp has also undertaken substantial equity fundraising initiatives:

1. Issuance of 25.58 crore equity shares at Rs. 4.71 per share
2. Conversion of 3.55 crore share warrants into equity shares
3. Issuance of 4.40 crore additional share warrants convertible into equity shares at Rs. 4.71 per share

These actions suggest that the company is actively seeking to strengthen its capital base, possibly to fund its expansion plans or improve its financial position.

Challenges and Risk Factors

While the company appears to be on a growth trajectory, it faces some challenges:

• Long-standing trade receivables amounting to Rs. 88.82 crore remain unrecovered as of September 30, 2025.
• The company has recognized a provision for doubtful debts of Rs. 66.52 crore against these outstanding receivables.
• Management expects to recover these amounts in subsequent quarters but has indicated that unrecovered portions may be written off if recovery efforts fail.

Looking Ahead

Shah Metacorp's recent corporate actions, including major acquisitions and equity fundraising, indicate a strategic shift that may significantly impact its future operations and financial performance. The company's ability to integrate its new subsidiaries effectively and address the challenges related to outstanding receivables will be crucial factors to watch in the coming quarters.

Investors and stakeholders will likely keep a close eye on how these developments translate into financial performance and whether the expanded business portfolio leads to improved revenues and profitability for Shah Metacorp Limited.

Shah Metacorp Limited has received trading approval from the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) for 25.58 crore equity shares, marking a significant corporate action for the company. This latest development involves a preferential allotment to both promoters and non-promoters at a price of Rs. 4.71 per share.

Latest Share Issuance Details

Official Trading Approvals

The company received official trading approval letters from both stock exchanges on December 29, 2025. BSE issued approval letter LOD/PREF/SV/483/2025-2026, while NSE provided approval under reference NSE/LIST/52366. Both exchanges confirmed that the shares are listed and admitted to dealings from December 30, 2025. The approvals were signed by designated officials including Kinnar Mehta and Pranav Rewale from BSE, and Jalpa Mehta from NSE.

Lock-in Period Details

The preferential allotment comes with specific lock-in arrangements for different tranches of shares:

Regulatory Compliance and Documentation

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shah Metacorp Limited has formally notified the stock exchanges about this development. The company submitted all required documentation to regulatory authorities, with Director Mona Viral Shah (DIN: 02343194) signing the official intimation letter on December 30, 2025.

Market Impact and Implications

This substantial preferential allotment of 25.58 crore shares represents a significant expansion in the company's equity base. The inclusion of both promoters and non-promoters in this allotment indicates a broader capital raising strategy. The issue price of Rs. 4.71 with a premium of Rs. 3.71 per share demonstrates the company's ability to raise funds at attractive valuations. Market participants will be closely monitoring the impact of this large equity infusion on the company's shareholding pattern and stock performance.